Skip to content

The Intensive Care Platform Trial (INCEPT)

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516208-41-00
Enrollment
20000
Registered
2025-02-18
Start date
2025-06-26
Completion date
Unknown
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute critical illness requiring intensive care unit admission.

Brief summary

Each domain in INCEPT will use one of the outcomes listed below under 'secondary end points' as the primary - the primary outcome will thus differ between domains, but always be one of the secondary outcomes (the core outcome set defined in the core protocol).

Detailed description

All-cause 30-day mortality, All-cause 90-day mortality, All-cause 180-day mortality, Days alive without life support at day 30, Days alive without life support at day 90, Days alive out of hospital at day 30, Days alive out of hospital at day 90, Days free of delirium at day 30, EQ-5D-5L index values (health-related quality of life) at day 180, EQ VAS (health-related quality of life) at day 180, Cognitive function at day 180 (Montreal Cognitive Assessment test 5-minute version, v2.1 [“Mini MoCA”]), One or more domain-specific safety outcomes

Interventions

DRUGinjektionsvæske
DRUGopløsning i fyldt injektionssprøjte med nålebeskytter
DRUGopløsning 20 %
DRUGopløsning i fyldt injektionssprøjte 2.500 anti-Xa IE
DRUGFraxiparine 2.850 IE/ 0
DRUG3 ml oplossing voor injectie
DRUGEnoxaparin "Becat"

Sponsors

Rigshospitalet
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Each domain in INCEPT will use one of the outcomes listed below under 'secondary end points' as the primary - the primary outcome will thus differ between domains, but always be one of the secondary outcomes (the core outcome set defined in the core protocol).

Secondary

MeasureTime frame
All-cause 30-day mortality, All-cause 90-day mortality, All-cause 180-day mortality, Days alive without life support at day 30, Days alive without life support at day 90, Days alive out of hospital at day 30, Days alive out of hospital at day 90, Days free of delirium at day 30, EQ-5D-5L index values (health-related quality of life) at day 180, EQ VAS (health-related quality of life) at day 180, Cognitive function at day 180 (Montreal Cognitive Assessment test 5-minute version, v2.1 [“Mini MoCA”]), One or more domain-specific safety outcomes

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026